标题
Metformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer
作者
关键词
-
出版物
MOLECULAR CARCINOGENESIS
Volume 56, Issue 2, Pages 349-358
出版商
Wiley
发表日期
2016-05-01
DOI
10.1002/mc.22498
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Resveratrol triggers ER stress-mediated apoptosis by disrupting N -linked glycosylation of proteins in ovarian cancer cells
- (2016) HyeRan Gwak et al. CANCER LETTERS
- Autophagy and protein kinase RNA-like endoplasmic reticulum kinase (PERK)/eukaryotic initiation factor 2 alpha kinase (eIF2α) pathway protect ovarian cancer cells from metformin-induced apoptosis
- (2015) Hee-sun Moon et al. MOLECULAR CARCINOGENESIS
- Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cells
- (2014) HyeRan Gwak et al. MOLECULAR CARCINOGENESIS
- Cyclin D1–Cdk4 controls glucose metabolism independently of cell cycle progression
- (2014) Yoonjin Lee et al. NATURE
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK
- (2014) X. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin against Cancer Stem Cells through the Modulation of Energy Metabolism: Special Considerations on Ovarian Cancer
- (2014) Tae Hun Kim et al. Biomed Research International
- A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr286, not Thr288
- (2013) Anne L. Ashford et al. BIOCHEMICAL JOURNAL
- Activator or inhibitor? GSK-3 as a new drug target
- (2013) Fumi Takahashi-Yanaga BIOCHEMICAL PHARMACOLOGY
- The LKB1-AMPK Pathway—Friend or Foe in Cancer?
- (2013) D. Grahame Hardie CANCER CELL
- Metformin intake is associated with better survival in ovarian cancer
- (2012) Sanjeev Kumar et al. CANCER
- Metformin targets ovarian cancer stem cells in vitro and in vivo
- (2012) Jessica J. Shank et al. GYNECOLOGIC ONCOLOGY
- Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects
- (2012) M A Pierotti et al. ONCOGENE
- Metabolic approaches to overcoming chemoresistance in ovarian cancer
- (2011) Dong Hoon Suh et al. Annals of the New York Academy of Sciences
- Overexpression of Glycogen Synthase Kinase-3 in Ovarian Carcinoma Cells With Acquired Paclitaxel Resistance
- (2011) Yunfeng Fu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Epidemiological characteristics of ovarian cancer in Korea
- (2011) Boyoung Park et al. Journal of Gynecologic Oncology
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells
- (2010) Nathan J Bowen et al. BMC Medical Genomics
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Glucose as a prognostic factor in ovarian carcinoma
- (2009) Donald M. Lamkin et al. CANCER
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
- GSK-3β regulates cyclin D1 expression: A new target for chemotherapy
- (2007) Fumi Takahashi-Yanaga et al. CELLULAR SIGNALLING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now